Apiotrichum veenhuisii isolated from a pediatric patient with acute myeloid leukemia: The first case in humans

Mycologia
Bruna Rossini LaraLuciana da Silva Ruiz

Abstract

This is the first report of the yeast Apiotrichum veenhuisii (formerly Trichosporon veenhuisii) causing disease in humans; its virulence and in vitro behavior against antifungals were also studied. The sample was isolated from biopsy fragments of disseminated lesions on the skin of a pediatric patient with acute myeloid leukemia. The studied virulence factors evidenced that the strain tested negative for secretion of the enzymes proteinase, phospholipase, and hemolysin. The isolate was characterized as low biofilm producer. Except for amphotericin B and voriconazole, the sample presented high minimum inhibitory concentration values against azole and echinocandins.

References

May 29, 2000·International Journal of Systematic and Evolutionary Microbiology·W J MiddelhovenJ W Fell
Jul 28, 2001·Journal of Clinical Microbiology·G LuoJ Y Yau
Mar 23, 2004·Nucleic Acids Research·Robert C Edgar
Jun 21, 2006·Systematic Biology·Maria Anisimova, Olivier Gascuel
Jul 14, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Noboru AsadaKosei Matsue
Apr 22, 2008·Nucleic Acids Research·A DereeperO Gascuel
Jan 12, 2010·European Journal of Haematology·Kei SuzukiNaoyuki Katayama
Oct 7, 2011·Clinical Microbiology Reviews·Arnaldo L ColomboGuilherme M Chaves
Oct 18, 2013·Molecular Biology and Evolution·Koichiro TamuraSudhir Kumar
Dec 11, 2014·Mikrobiyoloji bülteni·Feyza Demir, Semra Kuştimur
Mar 10, 2016·Studies in Mycology·X-Z LiuF-Y Bai

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.